Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_assertion description "[Treatment of CaCO-2 cells with rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, significantly reduced secretion of MMP-9, indicating that agents that activate PPAR-gamma may have therapeutic use in patients with IBD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_assertion evidence source_evidence_literature NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_assertion SIO_000772 11244573 NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_assertion wasDerivedFrom befree-20150227 NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_assertion wasGeneratedBy ECO_0000203 NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.
- befree-20150227 importedOn "2015-02-27" NP564049.RAV0bfz5Ma1YU0aO2VI2GNjulJpzzE1HIoYsl063jIf5U130_provenance.